Tech Company Financing Transactions
CymaBay Therapeutics Funding Round
Alta Partners, Bay City Capital and venBio joined a $3.3 million funding round for CymaBay Therapeutics. The round was recorded on 12/31/2013.
Transaction Overview
Company Name
Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
$3,321,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7575 Gateway Blvd. 110
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Website
Email Address
Overview
CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sujal Shah
Chief Scientific Officer
Charles McWherter
VP - Bus. Development
Patrick O'Mara
VP - Finance
Daniel Menold
VP - General Counsel
Paul Quinlan
VP - Manufacturing
Robert Martin
VP - Regulatory Affairs
Klara Dickinson
Browse more venture capital transactions:
Prev: 12/31/2013: Unitrends Software venture capital transaction
Next: 12/31/2013: Luxul Technology venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs